Amarin Pharma Inc is categorized under Commercial Research Laboratory in Bedminster, NJ and active since 2008.
Amarin Pharma Inc was established in 2008, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Commercial Research Laboratory business, which does work in the B2B market, and is classified as a Commercial Research Laboratory, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Joseph S Zakrzewski at the company’s single location by writing to 1430 Route 206 # 200, Bedminster, New Jersey NJ 07921 or by phoning (908) 719-1315. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Amarin Pharma Inc |
Contact Person: | Joseph S Zakrzewski |
Address: | 1430 Route 206 # 200, Bedminster, New Jersey 07921 |
Phone Number: | (908) 719-1315 |
Website Address: | amarincorp.com |
Annual Revenue (USD): | $2.500.000 to $4.999.999 |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Research Laboratory |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Amarin Pharma Inc was started in 2008 to provide professional Commercial Research Laboratory under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Joseph S Zakrzewski for inquiries that concern Amarin Pharma Inc by calling the company number (908) 719-1315, as your correspondence is most welcome. Additionally, the physical location of the single location of Amarin Pharma Inc can be found at the coordinates 40.677211,-74.648385 as well as the street address 1430 Route 206 # 200 in Bedminster, New Jersey 07921.
For its online presence, you may visit Amarin Pharma Inc’s website at amarincorp.com and engage with its social media outlets through on Twitter and on Facebook.